Stockreport

Novo beats Lilly to first FDA-approved GLP-1RA pill for obesity [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF The FDA has greenlit Novo's oral formulation of Wegovy (semaglutide) for the treatment of patients who are obese or overweight with weight-related medical problems. The [Read more]